Bifogade filer
Clarification to the PR Regarding Proposal for Change in the Board of Directors for Nanologica AB (publ)
Prenumeration
Beskrivning
| Land | Sverige |
|---|---|
| Lista | Small Cap Stockholm |
| Sektor | Hälsovård |
| Industri | Bioteknik |
The clarification is that it is the nomination committee of Nanologica AB that has presented the proposal to elect Alexandra Blomberg Montgomery to the board of directors of Nanologica AB.
The nomination committee, consisting of Carl-Johan Spak (Flerie Invest AB), Lennart Francke (Swedbank Robur funds), and Kalle Olby (Vega Bianca AB), has in connection with Nanologica AB preparing an Extraordinary General Meeting to be held on 23 September 2024, resolved to propose that the board of directors be increased by one member, namely Alexandra Blomberg Montgomery.
The nomination committee has interviewed Alexandra Blomberg Montgomery and finds that she has a suitable background and will be able to bring valuable expertise to the board. The current board of directors of Nanologica consists of five members elected by the Annual General Meeting and according to the articles of association, the board of directors shall consist of a minimum of three and a maximum of nine ordinary members. The nomination committee finds it appropriate to strengthen the board of directors in connection with the planned Extraordinary General Meeting and increase it to six ordinary members and continue without deputies.
The nomination committee proposes that Alexandra Blomberg Montgomery as a new board member receives remuneration on a par with the other board members, but adjusted with regard to when she takes up her position during the financial year.
The nomination committee believes that the board of directors has and will continue to have, with regard to the company's operations, stage of development and conditions in general, an appropriate composition with an even gender distribution and versatility in terms of competence, experience and background.